HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review (Q37923050)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 August 2011

Language	Label	Description	Also known as
English	HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review	scientific article published on 25 August 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

1 reference

Europe PubMed Central

HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

anti-retroviral agent

0 references

systematic review

1 reference

based on heuristic

inferred from title

Tobias F Rinke de Wit

5

object named as

Tobias F Rinke de Wit

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

author name string

Kim C E Sigaloff

1

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Job C J Calis

2

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sibyl P Geelen

3

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Michèle van Vugt

4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

publication date

25 August 2011

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Lancet Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

769-779

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Mechanisms and timing of mother-to-child transmission of HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Disease progression in a cohort of infants with vertically acquired HIV infection observed from birth: the Women and Infants Transmission Study (WITS).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Short-term risk of disease progression in HIV-1-infected children receiving no antiretroviral therapy or zidovudine monotherapy: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of Combination Therapy Including Protease Inhibitors on Mortality among Children and Adolescents Infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of highly active antiretroviral therapy in HIV-1 infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to combination antiretroviral therapy: variation by age.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Underdosing of antiretrovirals in UK and Irish children with HIV as an example of problems in prescribing medicines to children, 1997-2005: cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Adherence to antiretroviral therapy for pediatric HIV infection: a qualitative systematic review with recommendations for research and clinical management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in Cambodia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of virologic failure and genotypic resistance mutation patterns in thai children receiving non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Genotypic human immunodeficiency virus type 1 drug resistance in highly active antiretroviral therapy-treated children in Abidjan, Côte d'Ivoire

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Level of viral load and antiretroviral resistance after 6 months of non-nucleoside reverse transcriptase inhibitor first-line treatment in HIV-1-infected children in Mali

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to nonnucleoside reverse transcriptase inhibitor-based therapy in HIV-infected children with perinatal exposure to single-dose nevirapine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human immunodeficiency virus type 1: drug resistance in treated and untreated Brazilian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of HIV- type 1 protease and reverse transcriptase in Brazilian children failing highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

High frequency of BF mosaic genomes among HIV-1-infected children from Sao Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug resistance in the Chinese National Pediatric Highly Active Antiretroviral Therapy Cohort: implications for paediatric treatment in the developing world.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Protease inhibitor resistance in South African children with virologic failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 drug resistance in HIV-1-infected children in the United Kingdom from 1998 to 2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antiretroviral drug resistance among HIV-1 infected children failing treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

M184V is associated with a low incidence of thymidine analogue mutations and low phenotypic resistance to zidovudine and stavudine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Maternal viral genotypic zidovudine resistance and infrequent failure of zidovudine therapy to prevent perinatal transmission of human immunodeficiency virus type 1 in pediatric AIDS Clinical Trials Group Protocol 076.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic study of the variability of indinavir drug levels when boosted with ritonavir in HIV-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to antiretroviral therapy after a single, peripartum dose of nevirapine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Virologic rebound on HAART in the context of low treatment adherence is associated with a low prevalence of antiretroviral drug resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy for pediatric HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutations associated with virological response to darunavir/ritonavir in HIV-1-infected protease inhibitor-experienced patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing treatment-experienced pediatric and adolescent HIV patients: role of darunavir

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy, safety and tolerability of tipranavir coadministered with ritonavir in HIV-1-infected children and adolescents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970141-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1473-3099(11)70141-4

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37923050&oldid=2167142721"